... response Multidrug resistance Preoperative or neoadjuvant chemotherapy (NAT) has been widely used in locally advanced or inflammatory breast cancer. The patients who achieve pathological complete response (pCR) after NAT have a better long-term outcome [ 1, 2 ]. However, no biomarkers...

... for tumors. Moreover, overexpression of GLO1 was associated with multidrug resistance in cancer chemotherapy. This review describes the role of GLO1 in tumor cell proliferation and survival, and the potential of GLO1 as a biomarker for tumor diagnosis and as a target for anticancer drug development...